James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...

Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...

Among patients with grade group 1 prostate cancer, those belonging to higher risk groups were more likely to have adverse pathology and die from their disease. About 1 in 6 patients with grade group 1 ...

Are Some 'Low-Grade' Prostate Cancers More Deadly Than Thought? FRIDAY, August 1, 2025 (HealthDay News) — Men diagnosed with what are known as Grade Group one (GG1) prostate tumors are often told they ...

A US study of 300,000 prostate cancer patients found that 1 in 6 men diagnosed with Grade Group 1 cancer had higher-risk disease. Over 18,000 cases had clinical features suggesting surgery or ...

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

Meritage Homes (MTH) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $3.15 per share a year ago. These ...